291 related articles for article (PubMed ID: 4005780)
21. Phenotypic characteristics of cells derived from precursors of human melanoma.
Herlyn M; Herlyn D; Elder DE; Bondi E; LaRossa D; Hamilton R; Sears HF; Balaban G; Guerry D; Clark WH
Cancer Res; 1983 Nov; 43(11):5502-8. PubMed ID: 6616481
[TBL] [Abstract][Full Text] [Related]
22. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
[TBL] [Abstract][Full Text] [Related]
23. HMB-45 staining of dysplastic melanocytic nevi in melanoma risk groups.
Ahmed I; Piepkorn M; Goldgar DE; Cannon-Albright LA; Meyer LJ; Skolnick MH; Zone JJ
J Cutan Pathol; 1991 Aug; 18(4):257-60. PubMed ID: 1939784
[TBL] [Abstract][Full Text] [Related]
24. Comparison of macromelanosomes and autophagic giant melanosome complexes in nevocellular nevi, lentigo simplex and malignant melanoma.
Horikoshi T; Jimbow K; Sugiyama S
J Cutan Pathol; 1982 Oct; 9(5):329-39. PubMed ID: 7142520
[TBL] [Abstract][Full Text] [Related]
25. The histological spectrum of acquired nevi. An analysis of the intraepidermal melanocytic proliferation in common and dysplastic nevi.
Urso C; Bondi R
Pathol Res Pract; 1994 Jun; 190(6):609-14. PubMed ID: 7984520
[TBL] [Abstract][Full Text] [Related]
26. Positive reactivity of dysplastic melanocytes with a monoclonal antibody against melanoma melanosomes, MoAb HMSA-2.
Maeda K; Maeda K; Jimbow K
J Invest Dermatol; 1988 Sep; 91(3):247-50. PubMed ID: 3411143
[TBL] [Abstract][Full Text] [Related]
27. Melanocytic nevi simulant of melanoma with medicolegal relevance.
Massi G
Virchows Arch; 2007 Sep; 451(3):623-47. PubMed ID: 17653760
[TBL] [Abstract][Full Text] [Related]
28. Malignant melanoma, dysplastic melanocytic nevi, and Spitz tumors. Histologic classification and characteristics.
Barnhill RL
Clin Plast Surg; 2000 Jul; 27(3):331-60, viii. PubMed ID: 10941557
[TBL] [Abstract][Full Text] [Related]
29. Nuclear parameters in the superficial and deep portion of melanocytic lesions--a morphometrical investigation.
Smolle J; Soyer HP; Juettner FM; Hoedl S; Kerl H
Pathol Res Pract; 1988 Jun; 183(3):266-70. PubMed ID: 3420029
[TBL] [Abstract][Full Text] [Related]
30. c-KIT receptor expression in cutaneous malignant melanoma and benign melanotic naevi.
Ohashi A; Funasaka Y; Ueda M; Ichihashi M
Melanoma Res; 1996 Feb; 6(1):25-30. PubMed ID: 8640066
[TBL] [Abstract][Full Text] [Related]
31. Clinical diagnosis of dysplastic melanocytic nevi. A clinicopathologic correlation.
Kelly JW; Crutcher WA; Sagebiel RW
J Am Acad Dermatol; 1986 Jun; 14(6):1044-52. PubMed ID: 3722481
[TBL] [Abstract][Full Text] [Related]
32. Dysplastic nevi in relation to superficial spreading melanoma.
Titus-Ernstoff L; Barnhill RL; Duray PH; Ernstoff MS; Kirkwood JM
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):99-101. PubMed ID: 8467253
[TBL] [Abstract][Full Text] [Related]
33. Nevi, other than dysplastic and Spitz nevi.
Cochran AJ; Bailly C; Paul E; Dolbeau D
Semin Diagn Pathol; 1993 Feb; 10(1):3-17. PubMed ID: 8506415
[TBL] [Abstract][Full Text] [Related]
34. Common acquired melanocytic nevi, dysplastic melanocytic nevi and malignant melanomas: an image analysis cytometric study.
Bruijn JA; Berwick M; Mihm MC; Barnhill RL
J Cutan Pathol; 1993 Apr; 20(2):121-5. PubMed ID: 8320355
[TBL] [Abstract][Full Text] [Related]
35. Benign conjunctival melanocytic lesions. Clinicopathologic features.
Folberg R; Jakobiec FA; Bernardino VB; Iwamoto T
Ophthalmology; 1989 Apr; 96(4):436-61. PubMed ID: 2657539
[TBL] [Abstract][Full Text] [Related]
36. Dysplastic melanocytic nevus: Are molecular findings the key to the diagnosis?
Xavier-Junior JCC; Ocanha-Xavier JP
Ann Diagn Pathol; 2022 Oct; 60():152006. PubMed ID: 35839551
[TBL] [Abstract][Full Text] [Related]
37. Melanocytic nevi with features of Spitz nevi and Clark's/dysplastic nevi ("Spark's" nevi).
Ko CJ; McNiff JM; Glusac EJ
J Cutan Pathol; 2009 Oct; 36(10):1063-8. PubMed ID: 19187111
[TBL] [Abstract][Full Text] [Related]
38. Expression of cyclins A and E in melanocytic skin lesions and its correlation with some clinicopathologic features.
Alekseenko A; Wojas-Pelc A; Lis GJ; Wiśniowski Z; Czerwińska M; Niewiara Ł; Litwin JA
Folia Histochem Cytobiol; 2012 Jul; 50(2):263-9. PubMed ID: 22763964
[TBL] [Abstract][Full Text] [Related]
39. Dysplastic melanocytic nevi in histologic association with 234 primary cutaneous melanomas.
Rhodes AR; Harrist TJ; Day CL; Mihm MC; Fitzpatrick TB; Sober AJ
J Am Acad Dermatol; 1983 Oct; 9(4):563-74. PubMed ID: 6630618
[TBL] [Abstract][Full Text] [Related]
40. Dysplasia, dysplastic melanocytes, dysplastic nevi, the dysplastic nevus syndrome, and the relation between dysplastic nevi and malignant melanomas.
Ackerman AB; Mihara I
Hum Pathol; 1985 Jan; 16(1):87-91. PubMed ID: 3972389
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
